Gene Therapy for the Treatment of Neurological Disorders: Amyotrophic Lateral Sclerosis
Related Experiment Video
Updated: Jan 20, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
Zachary T McEachin1, Anthony Donsante1, Nicholas Boulis2
1Department of Neurosurgery, Emory University, Atlanta, GA, USA.
Abstract:
Gene therapy is a powerful tool for treating diseases, including neurological disorder such at amyotrophic lateral sclerosis. When delivered to the CNS, gene therapy vectors can provide prosurvival signals to neurons, knock down the expression of toxic proteins, or restore lost function. How to best deliver this type of therapeutic depends on the nature of the disease and the expected function of the transgene. Here we describe a method for parenchymal injection into rodent models, allowing for localized delivery of gene therapy vectors and other therapeutic molecules. This technique has been a robust mechanism for proof-of-principle experiments.
Related Concept Videos
09:36Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
08:27Evaluation of Motor Impairment in C. elegans Models of Amyotrophic Lateral Sclerosis
08:11Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
07:00Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
12:43A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)

